PHARMIDABLE
ActiveSummary
The computed 12-month bankruptcy probability of PHARMIDABLE is 3.7% (moderate). The 2024 annual accounts show equity of €31,742 and a net result of -€28,258. Its solvency ranks better than 25% of 25,572 sector peers (NACE 47, financial year 2024). The company has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals.
Group and network
Connections & network
3 current directorsThe board mandates are listed below; here you explore them as a network.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.